ArticleNature medicine2025

Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial.

Scott Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.